| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-06 |